Clinical Knowledge Summaries has advice on diagnosis and management of:
Prior to referral the following investigations are appropriate:
Hepatitis C is now curable with simple, easily tolerated treatment plans from just one tablet a day for 8-12 weeks.
Free and confidential home tests for hepatitis C now available via the NHS
A new NHS portal is offering hepatitis C home testing kits. Anyone over 18 living in England can order a free and confidential test by visiting Home - HepC (hepctest.nhs.uk)
UHBW's Hepatitis C Bristol and Severn Network website includes detailed information on HCV symptoms, treatment, support and testing, and includes a self-referral form for patients which, when completed is directly fed back to the hub centre to be allocated to treatment centres within the network, as requested by the responder.
We hope that prospective patients, or potentially their support network of friends and family, will be able to access this website to gain further information to encourage testing/treatment.
Please note that this website is currently primarily patient focused.
For further information, please contact the hepatitis C team on hepatitisnurses@uhbw.nhs.uk or ubh-tr.hepatitisnurses@nhs.net
Patients with Hepatitis C
All patients with active Hep C infection should be referred to UHBW via eRS (marked urgent) to be seen within 4 weeks (do not refer these patients to NBT).
Patients with hepatitis C or patients who would like to access a hepatitis C test can now also self refer via the Hepatitis C Bristol and Severn Network website
All other patients with Viral Hepatitis
Referrals for all other patients with viral hepatitis can be made via eRS and clinics are available at UHBW and NBT.
Urgent Referrals
Please see the Urgent Hepatology Service page for criteria for referral to urgent hepatology services.
(1) The Bristol and Severn Hepatitis C Network (uhbristol.nhs.uk)
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.